Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-alpha antagonists.
Lee, H-H
Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-alpha antagonists. [electronic resource] - The British journal of dermatology Mar 2007 - 486-91 p. digital
Publication Type: Journal Article
0007-0963
10.1111/j.1365-2133.2007.07682.x doi
Adalimumab
Adult
Aged
Antibodies, Monoclonal--adverse effects
Antibodies, Monoclonal, Humanized
Antirheumatic Agents--adverse effects
Dermatitis, Atopic--chemically induced
Drug Eruptions--etiology
Etanercept
Female
Humans
Immunoglobulin G--adverse effects
Immunologic Factors--adverse effects
Infliximab
Male
Middle Aged
Opportunistic Infections--chemically induced
Prospective Studies
Psoriasis--chemically induced
Receptors, Tumor Necrosis Factor
Rheumatic Diseases--drug therapy
Skin Diseases, Infectious--chemically induced
Tumor Necrosis Factor-alpha--antagonists & inhibitors
Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-alpha antagonists. [electronic resource] - The British journal of dermatology Mar 2007 - 486-91 p. digital
Publication Type: Journal Article
0007-0963
10.1111/j.1365-2133.2007.07682.x doi
Adalimumab
Adult
Aged
Antibodies, Monoclonal--adverse effects
Antibodies, Monoclonal, Humanized
Antirheumatic Agents--adverse effects
Dermatitis, Atopic--chemically induced
Drug Eruptions--etiology
Etanercept
Female
Humans
Immunoglobulin G--adverse effects
Immunologic Factors--adverse effects
Infliximab
Male
Middle Aged
Opportunistic Infections--chemically induced
Prospective Studies
Psoriasis--chemically induced
Receptors, Tumor Necrosis Factor
Rheumatic Diseases--drug therapy
Skin Diseases, Infectious--chemically induced
Tumor Necrosis Factor-alpha--antagonists & inhibitors